These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7852871)

  • 1. [Functional capacity of fibrinogen and erythrocyte aggregation in the diabetic].
    Khodabandehlou T; Le Devehat C; Razavian M; Boynard M; Ba M
    J Mal Vasc; 1994; 19(4):278-82. PubMed ID: 7852871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasminogen activation and erythrocyte aggregation in diabetic patients].
    Khodabandehlou T; Le Devehat C
    J Mal Vasc; 1994; 19(3):190-4. PubMed ID: 7798804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus and fibrinogen. Hemorrheological and microcirculatory consequences].
    Le Dévéhat C; Khodabandehlou T; Vimeux M
    J Mal Vasc; 2000 Feb; 25(1):53-7. PubMed ID: 10705136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell aggregation in diabetes mellitus.
    Le Devehat C; Vimeux M; Bondoux G; Khodabandehlou T
    Int Angiol; 1990; 9(1):11-5. PubMed ID: 2212794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane.
    Martínez M; Vayá A; Server R; Gilsanz A; Aznar J
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):253-8. PubMed ID: 9741665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-sensitive proteins and erythrocyte aggregation in atherothrombosis.
    Assayag EB; Bornstein N; Shapira I; Mardi T; Goldin Y; Tolshinski T; Vered Y; Zakuth V; Burke M; Berliner S; Bonet DS
    Int J Cardiol; 2005 Feb; 98(2):271-6. PubMed ID: 15686778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of albumin glycation on the erythrocyte aggregation: an in vitro study.
    Candiloros H; Muller S; Ziegler O; Donner M; Drouin P
    Diabet Med; 1996 Jul; 13(7):646-50. PubMed ID: 8840099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte aggregability and AB0 blood groups.
    Vayá A; Martínez Triguero M; Ricart A; Plumé G; Solves P; Corella D; Romagnoli M
    Clin Hemorheol Microcirc; 2009; 41(1):67-72. PubMed ID: 19136744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemorheological alterations in hypertensive patients].
    Foresto P; D'Arrigo M; Filippini F; Gallo R; Barberena L; Racca L; Valverde J; Rasia RJ
    Medicina (B Aires); 2005; 65(2):121-5. PubMed ID: 16075805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.
    Vayá A; Falcó C; Réganon E; Vila V; Martínez-Sales V; Corella D; Contreras MT; Aznar J
    Thromb Haemost; 2004 Feb; 91(2):354-9. PubMed ID: 14961164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen interaction with the red blood cell membrane.
    Saldanha C
    Clin Hemorheol Microcirc; 2013; 53(1-2):39-44. PubMed ID: 22960295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects.
    Pieters M; Covic N; Loots du T; van der Westhuizen FH; van Zyl DG; Rheeder P; Jerling JC; Weisel JW
    Thromb Haemost; 2006 Nov; 96(5):623-9. PubMed ID: 17080220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemorheological consequences of hyperglycaemic spike in healthy volunteers and insulin-dependent diabetics.
    Khodabandehlou T; Zhao H; Vimeux M; Aouane F; Le Devehat C
    Clin Hemorheol Microcirc; 1998 Oct; 19(2):105-14. PubMed ID: 9849923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocytes aggregation in healthy donors at native and standard hematocrit: the influence of sex, age, immunoglobulins and fibrinogen concentrations. Standardization of parameters.
    Korotaeva TV; Firsov NN; Bjelle A; Vishlova MA
    Clin Hemorheol Microcirc; 2007; 36(4):335-43. PubMed ID: 17502704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of fibrinogen levels on erythrocyte aggregation determined with the Myrenne aggregometer and the Sefam erythro-aggregometer.
    Falcó C; Vayá A; Simó M; Contreras T; Santaolaria M; Aznar J
    Clin Hemorheol Microcirc; 2005; 33(2):145-51. PubMed ID: 16151262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte hyperaggregation in obesity: determining factors and weight loss influence.
    Solá E; Vayá A; Corella D; Santaolaria ML; España F; Estellés A; Hernández-Mijares A
    Obesity (Silver Spring); 2007 Aug; 15(8):2128-34. PubMed ID: 17712132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ Methodological evaluation and clinical significance of erythrocyte aggregation].
    Carandente O; Rocco C; Falqui L
    Ric Clin Lab; 1985; 15 Suppl 1():39-50. PubMed ID: 2994203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood low shear rate rheometry: influence of fibrinogen level and hematocrit on slip and migrational effects.
    Picart C; Piau JM; Galliard H; Carpentier P
    Biorheology; 1998; 35(4-5):335-53. PubMed ID: 10474659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.